Institute of Anatomy, University of Bern, Bern, Switzerland.
J Heart Lung Transplant. 2010 Mar;29(3):327-34. doi: 10.1016/j.healun.2009.07.019. Epub 2009 Sep 26.
Pre-ischemic surfactant treatment attenuates ischemia/reperfusion (I/R) injury. In this study we investigate whether exogenous surfactant acts by influencing endogenous intra-alveolar and intracellular surfactant pools and subtype composition.
Rat lungs from control with (C + S) or without (C - S) surfactant treatment and I/R with (I/R + S) or without (I/R - S) surfactant treatment were analyzed. In I/R groups, lungs underwent ischemic storage for 4 hours at 4 degrees C and reperfusion for 60 minutes. The ultrastructure of intra-alveolar and intracellular surfactant forms fixed in their natural localization and microorganization was investigated by light- and electron-microscopic stereology.
Only slight differences in alveolar epithelial Type II cell number or volume and lamellar body parameters were observed. Intra-alveolar surfactant volume was significantly enhanced in C + S and I/R + S. I/R increased inactivated surfactant forms (unilamellar vesicles) in untreated [mean (SD): C - S: 26.0% (8.0%) vs I/R - S: 64.8% (5.5%); p < 0.01], but not in surfactant-treated rats [I/R + S: 23.5% (11.5%); p < 0.01 vs I/R - S]. The increase in unilamellar vesicles was closely correlated with intra-alveolar edema and decreased perfusate oxygenation.
Attenuation of I/R injury by pre-ischemic exogenous surfactant treatment is mainly based on stabilizing and increasing the active endogenous intra-alveolar surfactant pool.
缺血前表面活性剂处理可减轻缺血/再灌注(I/R)损伤。在这项研究中,我们研究了外源性表面活性剂是否通过影响肺泡内和细胞内表面活性剂池和亚类组成来发挥作用。
分析了来自对照(C+S)或无(C-S)表面活性剂处理以及有(I/R+S)或无(I/R-S)表面活性剂处理的 I/R 的大鼠肺。在 I/R 组中,肺在 4°C 下缺血储存 4 小时,并进行 60 分钟再灌注。通过光镜和电子显微镜体视学研究了固定在其自然定位和微组织中的肺泡内和细胞内表面活性剂形式的超微结构。
仅观察到肺泡上皮 II 型细胞数量或体积和板层体参数的轻微差异。C+S 和 I/R+S 中肺泡内表面活性剂体积显著增加。I/R 增加了未处理的[平均值(SD):C-S:26.0%(8.0%)比 I/R-S:64.8%(5.5%);p<0.01]失活的表面活性剂形式(单室小泡),但在表面活性剂处理的大鼠中没有增加[I/R+S:23.5%(11.5%);p<0.01 比 I/R-S]。单室小泡的增加与肺泡内水肿和灌流液氧合减少密切相关。
缺血前外源性表面活性剂处理减轻 I/R 损伤主要基于稳定和增加活跃的内源性肺泡内表面活性剂池。